Spruce Launches MPS IIIB Resource Website Ahead Of Planned TA-ERT Study In Q4

Spruce Biosciences, Inc. (SPRB), a late-stage biopharmaceutical company developing therapies for neurological disorders, announced the launch of MPS3BStudy.com, a resource for families and caregivers of children with Sanfilippo Syndrome Type B (MPS IIIB).